Radiant Revenue Cycles for Dermatology.
Dermatology billing services span the widest procedure range of almost any outpatient specialty — from a simple shave removal to multi-stage Mohs surgery — and each carries its own CPT rules, modifier requirements, and documentation standards. One miscoded biopsy or missing -25 modifier and the claim comes back denied.
In dermatology, the difference between a clean claim and a denial is often a single modifier.
With dozens of patients a day and multiple biopsies per encounter, a single coding oversight can lead to a mountain of denials. Dermatology billing requires a deep understanding of surgical stages and the “medical necessity” of skin procedures.Dermatology practices perform a high volume of E/M services and procedures on the same visit — and modifier -25 (significant, separately identifiable E/M on the same day as a procedure) is required every time. Without it, the payer bundles the office visit into the procedure payment and the E/M is lost. That’s the most common denial in dermatology. Add in biopsy code selection across the 11102–11107 range (each maps to a different technique), shave removal coding (11300–11313 by lesion size), excision coding (11400–11646 by site and size), and Mohs surgery (17311–17315 by stage and area), and dermatology billing becomes one of the most code-intensive workflows in outpatient medicine. Our full RCM services include dermatology-specific scrubbing built for this complexity.
Biopsy Coding: The 11102–11107 Range
Biopsy codes changed significantly with the 2019 CPT revision and are still a source of consistent coding errors. Code selection depends on technique: 11102 for tangential biopsy (shave), 11103 for each additional tangential lesion; 11104 for punch biopsy, 11105 for each additional punch; 11106 for incisional biopsy, 11107 for each additional incisional. Billing 11102 for a punch biopsy, or 11104 for an incisional biopsy, is both a coding error and an audit trigger. Pathology coordination (88305 surgical pathology) adds another billing layer that must be tracked when the practice owns its own lab versus referring specimens out.
Mohs Surgery: Stage-Based Coding
Mohs surgery codes (17311–17315) are billed per stage per area — not per case. Code 17311 covers the first stage on the head, neck, hands, feet, or genitalia; 17312 is the add-on for each additional stage in those locations. Code 17313 covers the first stage on the trunk, arms, or legs; 17314 is the add-on. The Mohs surgeon must personally perform both the excision and the histologic examination to bill these codes — assistant surgeon billing rules and pathology separation both create compliance risk when the practice model doesn't match the code definition.
Destruction Codes and Cryotherapy
Destruction codes (17000–17286) cover cryotherapy, laser ablation, and electrosurgery for benign, premalignant, and malignant lesions. Code 17000 covers destruction of the first premalignant lesion; 17003 is the add-on for lesions two through fourteen; 17004 covers fifteen or more in a single session. Phototherapy billing (96900–96999) requires documentation of treatment dose, exposure time, and clinical indication. These are frequently undercoded because staff default to generic destruction codes rather than applying the correct quantity-based add-on structure.
Biologic Drug Administration: Buy-and-Bill and J-Codes
Biologics like Dupixent, Skyrizi, and Humira represent a growing share of dermatology revenue — and billing them correctly requires navigating J-codes, buy-and-bill versus specialty pharmacy routing, and waste documentation for partially used vials. When a practice purchases and administers a biologic in-office, the drug is billed by J-code plus the appropriate administration code (96401 for non-chemotherapy injection). Medical necessity documentation and prior authorization must be in place before infusion — and buy-and-bill economics only work if the practice is credentialed for in-office drug administration with each payer.
Happy Billing Benchmarks for Dermatology:
98% First-Pass Clean Claim Rate
Dermatology claims fail most often on modifier -25 omission, wrong biopsy code technique, and missing or incorrect lesion count coding. We catch all three before the claim reaches the payer.
Zero Modifier -25 Revenue Loss
Every same-day E/M and procedure claim is reviewed for correct modifier -25 documentation before submission. This single step recovers a significant amount of revenue for most dermatology practices we onboard.
Mohs Stage Accuracy
Every Mohs surgery claim is reviewed against the operative note for correct stage count, anatomic location, and provider qualification. Stage errors in Mohs billing are both revenue losses and compliance risks.
A/R Under 35 Days
Dermatology practices carry high-volume, low-to-mid-dollar claims alongside occasional high-dollar Mohs and biologic administration claims. Our 24/7 team works the full claim spectrum continuously.
Our Specialized Process
Modifier -25 Compliance Audit
Every claim involving a same-day E/M and procedure is reviewed for modifier -25 — and for adequate documentation supporting a separately identifiable E/M service. This is the single highest-yield fix for most dermatology practices: recovering E/M revenue that was previously being bundled away.
Biopsy and Lesion Code Validation
We match biopsy codes (11102–11107), shave removals (11300–11313), and excision codes (11400–11646) to the operative note — technique, site, and lesion size — before every claim. No more systematic undercoding or overcoding that triggers payer audits.
Destruction Code Quantity Review
Every destruction claim is reviewed for correct quantity coding — particularly the 17000/17003/17004 add-on structure for cryotherapy and the phototherapy documentation requirements. Lesion count accuracy is confirmed against the procedure note.
Biologic Prior Auth and J-Code Management
We manage the full prior authorization lifecycle for biologic medications and handle J-code billing, drug administration coding, and waste documentation. Buy-and-bill revenue is protected; PA lapses that create write-offs are eliminated.
Built for the Way You Practice.
We work inside the EHRs that dermatology practices rely on daily — no migration, no disruption. Our team is expert-certified in:
EMA (ModMed) | Nextech | eClinicalWorks | Athena Health | Epic
Frequently Asked Questins
What documentation is needed to support modifier -25 on same-day procedure visits?
The E/M must be documented as a significant, separately identifiable service — with its own history, examination, and medical decision-making that goes beyond the pre- and post-procedure work already built into the procedure code. A note that reads only “patient presenting for lesion removal” does not support a separate E/M. A note that addresses an additional complaint, medication management, or a new diagnosis alongside the procedure does.
How do you handle billing when a biopsy result changes the diagnosis and treatment plan?
When a benign biopsy leads to a different treatment at a subsequent visit, no billing change to the original encounter is needed. When a biopsy result leads to an excision in the global period of the biopsy code, modifier -58 (staged procedure) may apply. When the pathology result changes the diagnosis code entirely, we update the claim with the corrected ICD-10 before filing — or file the subsequent encounter with the confirmed malignancy code from the pathology report.
Can you manage the buy-and-bill process for biologic medications?
Yes. We handle J-code billing, prior authorization, drug administration coding, and waste reporting for in-office biologic administration — including Dupixent (J0222), Humira (J0135), and Skyrizi (J2682). We also track payer-specific requirements for medical necessity documentation and step therapy compliance.
How do you code Mohs surgery when multiple surgeons are involved?
Mohs surgery is typically performed by a single surgeon who acts as both the excisional surgeon and the pathologist. If a second provider reads the pathology, the case cannot be billed as Mohs — it must be billed as a standard excision plus separate pathology. We confirm provider qualification before coding any Mohs claim.
Do you handle cosmetic procedure billing differently from medical dermatology?
Yes. Cosmetic procedures are non-covered by definition and billed directly to the patient at practice-set fees. We set up the billing separation between cosmetic self-pay and medically necessary services to prevent any inadvertent insurance billing of non-covered cosmetic work — which is both a denial trigger and a compliance risk.
Is your dermatology billing getting under your skin?
From biopsy to biologic, every service your practice delivers deserves proper reimbursement. Happy Billing’s dermatology RCM specialists handle the code-level complexity — so your financial health stays as strong as your clinical outcomes.
For practices with overlapping patient populations, explore our Internal Medicine billing services, General Surgery billing services, and Pediatrics billing services.